JP2022503850A5 - - Google Patents
Info
- Publication number
- JP2022503850A5 JP2022503850A5 JP2021517420A JP2021517420A JP2022503850A5 JP 2022503850 A5 JP2022503850 A5 JP 2022503850A5 JP 2021517420 A JP2021517420 A JP 2021517420A JP 2021517420 A JP2021517420 A JP 2021517420A JP 2022503850 A5 JP2022503850 A5 JP 2022503850A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- nucleotides
- construct according
- acid portion
- nucleotide
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862738222P | 2018-09-28 | 2018-09-28 | |
| US62/738,222 | 2018-09-28 | ||
| PCT/IB2019/058221 WO2020065602A2 (en) | 2018-09-28 | 2019-09-27 | Products and compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022503850A JP2022503850A (ja) | 2022-01-12 |
| JP2022503850A5 true JP2022503850A5 (https=) | 2022-09-28 |
| JPWO2020065602A5 JPWO2020065602A5 (https=) | 2022-09-28 |
Family
ID=69951906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517420A Pending JP2022503850A (ja) | 2018-09-28 | 2019-09-27 | 産物及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210371861A1 (https=) |
| EP (1) | EP3856200A4 (https=) |
| JP (1) | JP2022503850A (https=) |
| KR (1) | KR20210093851A (https=) |
| CN (1) | CN113164507A (https=) |
| AU (1) | AU2019346148A1 (https=) |
| BR (1) | BR112021005777A2 (https=) |
| CA (1) | CA3110300A1 (https=) |
| IL (1) | IL281684A (https=) |
| WO (1) | WO2020065602A2 (https=) |
| ZA (1) | ZA202101298B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250000892A1 (en) * | 2021-10-14 | 2025-01-02 | Arizona Board Of Regents On Behalf Of Arizona State University | Programmable delivery platforms for rna structures |
| WO2023069707A2 (en) * | 2021-10-22 | 2023-04-27 | Sirnaomics, Inc. | Products and compositions |
| WO2023240249A1 (en) * | 2022-06-11 | 2023-12-14 | Sirnaomics, Inc. | Products and compositions |
| WO2024059873A2 (en) * | 2022-09-16 | 2024-03-21 | Sirnaomics, Inc. | Products and compositions |
| WO2024081922A1 (en) * | 2022-10-14 | 2024-04-18 | Arizona Board Of Regents On Behalf Of Arizona State University | Modular rna delivery platforms and methods of their use |
| WO2024164001A2 (en) * | 2023-02-03 | 2024-08-08 | Sirnaomics, Inc. | Products and compositions |
| WO2024216267A2 (en) * | 2023-04-14 | 2024-10-17 | Sirnaomics, Inc. | Products and compositions |
| WO2024229229A2 (en) * | 2023-05-02 | 2024-11-07 | Sirnaomics, Inc. | Products and compositions |
| TW202526017A (zh) | 2023-09-14 | 2025-07-01 | 美商Ionis製藥公司 | 用於減少ａｐｏｃｉｉｉ表現的化合物及方法 |
| WO2025064821A2 (en) | 2023-09-21 | 2025-03-27 | Ionis Pharmaceuticals, Inc. | Compounds and methods for inhibiting lpa |
| WO2025259875A1 (en) * | 2024-06-12 | 2025-12-18 | Sirnaomics, Inc. | Novel antibody oligonucleotide drug conjugates containing gemcitibine for pharmaceutical compositions and related methods of use and treatment |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1989307B1 (en) * | 2006-02-08 | 2012-08-08 | Quark Pharmaceuticals, Inc. | NOVEL TANDEM siRNAS |
| US8252526B2 (en) * | 2006-11-09 | 2012-08-28 | Gradalis, Inc. | ShRNA molecules and methods of use thereof |
| EP2318528A1 (en) * | 2008-07-24 | 2011-05-11 | Rxi Pharmaceuticals Corporation | Rnai constructs and uses therof |
| EP2395085B1 (en) * | 2009-02-04 | 2015-06-10 | Sungkyunkwan University Foundation for Corporate Collaboration | Small interference rna complex with increased intracellular transmission capacity |
| ES2804764T3 (es) * | 2009-06-01 | 2021-02-09 | Halo Bio Rnai Therapeutics Inc | Polinucleótidos para la interferencia de ARN multivalente, composiciones y métodos de uso de los mismos |
| WO2015164818A1 (en) * | 2014-04-25 | 2015-10-29 | Strike Bio, Inc. | Multiple targeted rnai for the treatment of cancers |
| EP4365291A3 (en) * | 2015-06-12 | 2024-08-14 | Alnylam Pharmaceuticals, Inc. | Complement component c5 irna compositions and methods of use thereof |
| IL316159A (en) * | 2015-06-15 | 2024-12-01 | Mpeg La Llc | Defined Oligonucleotide Multimers and Methods for Manufacture Thereof |
| US10689654B2 (en) * | 2016-10-18 | 2020-06-23 | Augusta University Research Institute, Inc. | Bivalent siRNA chimeras and methods of use thereof |
| CN108342386B (zh) * | 2017-01-22 | 2022-04-15 | 广州市锐博生物科技有限公司 | 一种多聚寡核酸分子及其在多靶标干扰中的应用 |
| WO2020014948A1 (zh) * | 2018-07-20 | 2020-01-23 | 广州市锐博生物科技有限公司 | 核酸单元及其聚合核酸与应用 |
-
2019
- 2019-09-27 CN CN201980063688.9A patent/CN113164507A/zh active Pending
- 2019-09-27 CA CA3110300A patent/CA3110300A1/en active Pending
- 2019-09-27 EP EP19866965.7A patent/EP3856200A4/en active Pending
- 2019-09-27 AU AU2019346148A patent/AU2019346148A1/en not_active Abandoned
- 2019-09-27 WO PCT/IB2019/058221 patent/WO2020065602A2/en not_active Ceased
- 2019-09-27 JP JP2021517420A patent/JP2022503850A/ja active Pending
- 2019-09-27 KR KR1020217009902A patent/KR20210093851A/ko not_active Withdrawn
- 2019-09-27 BR BR112021005777A patent/BR112021005777A2/pt not_active IP Right Cessation
-
2021
- 2021-02-25 ZA ZA2021/01298A patent/ZA202101298B/en unknown
- 2021-03-21 IL IL281684A patent/IL281684A/en unknown
- 2021-03-29 US US17/215,964 patent/US20210371861A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022503850A5 (https=) | ||
| JP2021533804A5 (https=) | ||
| EP3503730B1 (en) | Compositions comprising reversibly modified oligonucleotides and uses thereof | |
| EP3506909B1 (en) | 4'-phosphate analogs and oligonucleotides comprising the same | |
| JP2022503850A (ja) | 産物及び組成物 | |
| JP7535047B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| CN115397436B (zh) | 用于抑制PNPLA3表达的RNAi剂、其药物组合物和使用方法 | |
| TW202126809A (zh) | 具有最小氟含量之小干擾rna的化學修飾 | |
| JPWO2020041769A5 (https=) | ||
| IL294728A (en) | lrrk2 RNA material preparations and methods of using them | |
| JPWO2020065602A5 (https=) | ||
| EP3677680A1 (en) | Small guide antisense nucleic acid and use thereof | |
| US20210332358A1 (en) | MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF | |
| WO2021157730A1 (ja) | 核酸医薬とその使用 | |
| WO2022266486A2 (en) | Products and compositions | |
| RU2021108050A (ru) | Нацеленные на множество целей конструкции нуклеиновой кислоты, составленные из множества олигонуклеотидов, которые модулируют экспрессию генов посредством комплементарного взаимодействия с целями | |
| CN116478997B (zh) | 用于抑制FGL1的siRNA及其修饰物与应用 | |
| JPWO2021150969A5 (https=) | ||
| WO2024229229A2 (en) | Products and compositions | |
| WO2024216267A2 (en) | Products and compositions | |
| HK40057705A (en) | Multi-targeting nucleic acid constructs composed of multiple oligonucleotides that modulate gene expression through complimentary interactions with targets | |
| RU2021107156A (ru) | МИНИАТЮРНЫЕ ШПИЛЕЧНЫЕ ТРИГГЕРЫ РНКи (mxRNA) И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| WO2024254589A9 (en) | Products and compositions | |
| CN120648679A (zh) | 抑制dmpk表达的多核苷酸分子及其用途 | |
| WO2024164001A2 (en) | Products and compositions |